210 related articles for article (PubMed ID: 19826420)
1. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease.
Lutgens MW; Oldenburg B; Siersema PD; van Bodegraven AA; Dijkstra G; Hommes DW; de Jong DJ; Stokkers PC; van der Woude CJ; Vleggaar FP
Br J Cancer; 2009 Nov; 101(10):1671-5. PubMed ID: 19826420
[TBL] [Abstract][Full Text] [Related]
2. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
[TBL] [Abstract][Full Text] [Related]
3. High frequency of early colorectal cancer in inflammatory bowel disease.
Lutgens MW; Vleggaar FP; Schipper ME; Stokkers PC; van der Woude CJ; Hommes DW; de Jong DJ; Dijkstra G; van Bodegraven AA; Oldenburg B; Samsom M
Gut; 2008 Sep; 57(9):1246-51. PubMed ID: 18337322
[TBL] [Abstract][Full Text] [Related]
4. Root-cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease.
Gordon C; Chee D; Hamilton B; Heerasing NM; Hendy P; Chanchlani N; Lin S; Wesley E; Daniels IR; Silva N; Osborne M; Kennedy NA; Goodhand JR; Ahmad T
Aliment Pharmacol Ther; 2021 Jan; 53(2):291-301. PubMed ID: 33159472
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness of Surveillance Colonoscopy Intervals on Colorectal Cancer Outcomes in a National Cohort of Patients with Inflammatory Bowel Disease.
Kim HS; Hernaez R; Sansgiry S; Waljee AK; Scott FI; Lewis JD; El-Serag HB; Hou JK
Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2848-2857.e2. PubMed ID: 35240331
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Interval Colorectal Cancer Among Inflammatory Bowel Disease Patients Undergoing Regular Colonoscopic Surveillance.
Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; van Bodegraven AA; Jansen JM; Mahmmod N; Kremer W; Siersema PD; Oldenburg B;
Clin Gastroenterol Hepatol; 2015 Sep; 13(9):1656-61. PubMed ID: 25956835
[TBL] [Abstract][Full Text] [Related]
7. [British and American screening guidelines inadequate for prevention of colorectal carcinoma in patients with inflammatory bowel disease].
Vleggaar FP; Lutgens MW; Oldenburg B; Schipper ME; Samsom M
Ned Tijdschr Geneeskd; 2007 Dec; 151(50):2787-91. PubMed ID: 18232199
[TBL] [Abstract][Full Text] [Related]
8. Colon cancer surveillance in inflammatory bowel disease: unclear gain but no psychological pain?
Mountifield R; Bampton P; Prosser R; Mikocka-Walus A; Andrews JM
Intern Med J; 2014 Feb; 44(2):131-8. PubMed ID: 24383700
[TBL] [Abstract][Full Text] [Related]
9. Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.
Klepp P; Kisiel JB; Småstuen MC; Røseth A; Andersen SN; Vatn MH; Ahlquist DA; Moum BA; Brackmann S
Scand J Gastroenterol; 2018 Mar; 53(3):273-278. PubMed ID: 29313389
[TBL] [Abstract][Full Text] [Related]
10. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
[TBL] [Abstract][Full Text] [Related]
11. More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis.
Claessen MM; Lutgens MW; van Buuren HR; Oldenburg B; Stokkers PC; van der Woude CJ; Hommes DW; de Jong DJ; Dijkstra G; van Bodegraven AA; Siersema PD; Vleggaar FP
Inflamm Bowel Dis; 2009 Sep; 15(9):1331-6. PubMed ID: 19229982
[TBL] [Abstract][Full Text] [Related]
12. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
[TBL] [Abstract][Full Text] [Related]
13. No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies.
Engel C; Vasen HF; Seppälä T; Aretz S; Bigirwamungu-Bargeman M; de Boer SY; Bucksch K; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Järvinen H; Kloor M; von Knebel Doeberitz M; Koornstra JJ; van Kouwen M; Langers AM; van de Meeberg PC; Morak M; Möslein G; Nagengast FM; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Sanduleanu S; Schackert HK; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vecht J; Verhulst ML; de Vos Tot Nederveen Cappel W; Zachariae S; Mecklin JP; Loeffler M;
Gastroenterology; 2018 Nov; 155(5):1400-1409.e2. PubMed ID: 30063918
[TBL] [Abstract][Full Text] [Related]
14. Use of surveillance colonoscopy in medicare patients with inflammatory bowel disease prior to colorectal cancer diagnosis.
Wang YR; Cangemi JR; Loftus EV; Picco MF
Digestion; 2014; 90(1):58-62. PubMed ID: 25196002
[TBL] [Abstract][Full Text] [Related]
15. Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry.
Adams SV; Ahnen DJ; Baron JA; Campbell PT; Gallinger S; Grady WM; LeMarchand L; Lindor NM; Potter JD; Newcomb PA
World J Gastroenterol; 2013 Jun; 19(21):3241-8. PubMed ID: 23745025
[TBL] [Abstract][Full Text] [Related]
16. Decentralized colonoscopic surveillance with high patient compliance prevents hereditary and familial colorectal cancer.
Sjöström O; Lindholm L; Tavelin B; Melin B
Fam Cancer; 2016 Oct; 15(4):543-51. PubMed ID: 26935832
[TBL] [Abstract][Full Text] [Related]
17. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
18. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
Lutgens M; Vermeire S; Van Oijen M; Vleggaar F; Siersema P; van Assche G; Rutgeerts P; Oldenburg B;
Clin Gastroenterol Hepatol; 2015 Jan; 13(1):148-54.e1. PubMed ID: 25041864
[TBL] [Abstract][Full Text] [Related]
19. Disease severity does not affect the interval between IBD diagnosis and the development of CRC: results from two large, Dutch case series.
Mooiweer E; Baars JE; Lutgens MW; Vleggaar F; van Oijen M; Siersema PD; Kuipers EJ; van der Woude CJ; Oldenburg B
J Crohns Colitis; 2012 May; 6(4):435-40. PubMed ID: 22398065
[TBL] [Abstract][Full Text] [Related]
20. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
